Study of the use possibility of the chemical-biological adduct of the 1,1-bis-[5-bromopyrimidine-2’,4’-diono-1’-il]-2-bromo-2’-chloroethylene and bacterial lectin for the treatment of the Pliss’ lymphosarcoma
Aim. Study of the pyrimidine metabolism antimetabolites that can be preformed compounds in the link of biosynthetic processes and can brake tumour’s growth is a more successful, perspective finding direction of new antitumor medications. New original chemical-biological adduct was studied as potenti...
Main Author: | O. V. Welchinska |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2015-04-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/42048/38339 |
Similar Items
-
Antitumour activity of 1,1-bis-(pyrimidine-2,4-diono-1-il)-2-bromo-2-chloroethylenes substituted molecular complexes and bacterial lectin
by: E. V. Welchinska
Published: (2015-04-01) -
An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer
by: Małgorzata Milczarek, et al.
Published: (2023-08-01) -
PHOTODYNAMIC THERAPY IN MULTIMODALITY TREATMENT OF PLISS LYMPHOSARCOMA AND UTERINE CERVIX CANCER-5
by: Vasileuski A. P., et al.
Published: (2020-12-01) -
Molecular features that predict the response to antimetabolite chemotherapies
by: Mahya Mehrmohamadi, et al.
Published: (2017-10-01) -
Xeloda as first-line therapy of metastatic colorectal cancer-our experience
by: Kovčin Vladimir, et al.
Published: (2002-01-01)